Covered recipient · General Payments record
CHARLES L THIEMANN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,042.00
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $550.02 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $134.77 | 6 |
| Novo Nordisk AS | $109.44 | 6 |
| Lilly USA, LLC | $107.11 | 6 |
| PFIZER INC. | $91.35 | 5 |
| GlaxoSmithKline, LLC. | $34.98 | 2 |
| Merck Sharp & Dohme Corporation | $29.48 | 2 |
| Exact Sciences Corporation | $22.56 | 1 |
| DEXCOM, INC. | $20.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.86 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106216763 | CMS |
| ABBVIE INC. | $23.31 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106216765 | CMS |
| ABBVIE INC. | $31.42 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106216767 | CMS |
| ABBVIE INC. | $23.10 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106216769 | CMS |
| ABBVIE INC. | $14.78 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106216771 | CMS |
| ABBVIE INC. | $16.30 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106216773 | CMS |
| Dexcom, Inc. | $20.33 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291239 | CMS |
| Exact Sciences Corporation | $22.56 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114501319 | CMS |
| GlaxoSmithKline, LLC. | $15.84 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116417422 | CMS |
| GlaxoSmithKline, LLC. | $19.14 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116722299 | CMS |
| Lilly USA, LLC | $18.80 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136102870 | CMS |
| Lilly USA, LLC | $17.81 | 05/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136113398 | CMS |
| Lilly USA, LLC | $16.15 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136095601 | CMS |
| Lilly USA, LLC | $17.16 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136102872 | CMS |
| Lilly USA, LLC | $16.26 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136092796 | CMS |
| Lilly USA, LLC | $20.93 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136094107 | CMS |
| Merck Sharp & Dohme LLC | $14.97 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141968139 | CMS |
| Merck Sharp & Dohme LLC | $14.51 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141674885 | CMS |
| Novo Nordisk Inc | $16.20 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097834380 | CMS |
| Novo Nordisk Inc | $16.73 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096924120 | CMS |
| Novo Nordisk Inc | $17.83 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097692125 | CMS |
| Novo Nordisk Inc | $18.38 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096816536 | CMS |
| Novo Nordisk Inc | $13.75 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097022555 | CMS |
| Novo Nordisk Inc | $26.55 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096908955 | CMS |
| PFIZER INC. | $19.35 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131207966 | CMS |
| PFIZER INC. | $22.29 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131620621 | CMS |
| PFIZER INC. | $14.81 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131611444 | CMS |
| PFIZER INC. | $13.87 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131160887 | CMS |
| PFIZER INC. | $21.03 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131197102 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.